Literature DB >> 18070924

Abnormal heart development and lung remodeling in mice lacking the hypoxia-inducible factor-related basic helix-loop-helix PAS protein NEPAS.

Toshiharu Yamashita1, Osamu Ohneda, Masumi Nagano, Motoyuki Iemitsu, Yuichi Makino, Hirotoshi Tanaka, Takashi Miyauchi, Katsutoshi Goto, Kinuko Ohneda, Yoshiaki Fujii-Kuriyama, Lorenz Poellinger, Masayuki Yamamoto.   

Abstract

Hypoxia-inducible factors (HIFs) are crucial for oxygen homeostasis during both embryonic development and postnatal life. Here we show that a novel HIF family basic helix-loop-helix (bHLH) PAS (Per-Arnt-Sim) protein, which is expressed predominantly during embryonic and neonatal stages and thereby designated NEPAS (neonatal and embryonic PAS), acts as a negative regulator of HIF-mediated gene expression. NEPAS mRNA is derived from the HIF-3alpha gene by alternative splicing, replacing the first exon of HIF-3alpha with that of inhibitory PAS. NEPAS can dimerize with Arnt and exhibits only low levels of transcriptional activity, similar to that of HIF-3alpha. NEPAS suppressed reporter gene expression driven by HIF-1alpha and HIF-2alpha. By generating mice with a targeted disruption of the NEPAS/HIF-3alpha locus, we found that homozygous mutant mice (NEPAS/HIF-3alpha(-)(/)(-)) were viable but displayed enlargement of the right ventricle and impaired lung remodeling. The expression of endothelin 1 and platelet-derived growth factor beta was increased in the lung endothelial cells of NEPAS/HIF-3alpha-null mice. These results demonstrate a novel regulatory mechanism in which the activities of HIF-1alpha and HIF-2alpha are negatively regulated by NEPAS in endothelial cells, which is pertinent to lung and heart development during the embryonic and neonatal stages.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18070924      PMCID: PMC2258751          DOI: 10.1128/MCB.01332-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  Novel molecular mechanism of increased myocardial endothelin-1 expression in the failing heart involving the transcriptional factor hypoxia-inducible factor-1alpha induced for impaired myocardial energy metabolism.

Authors:  Y Kakinuma; T Miyauchi; K Yuki; N Murakoshi; K Goto; I Yamaguchi
Journal:  Circulation       Date:  2001-05-15       Impact factor: 29.690

2.  Mouse model of desmin-related cardiomyopathy.

Authors:  X Wang; H Osinska; G W Dorn; M Nieman; J N Lorenz; A M Gerdes; S Witt; T Kimball; J Gulick; J Robbins
Journal:  Circulation       Date:  2001-05-15       Impact factor: 29.690

Review 3.  Oxygen(es) and the hypoxia-inducible factor-1.

Authors:  R H Wenger; M Gassmann
Journal:  Biol Chem       Date:  1997-07       Impact factor: 3.915

4.  [Treatment of persistent pulmonary hypertension of the newborn]

Authors:  C Suguihara
Journal:  J Pediatr (Rio J)       Date:  2001-07       Impact factor: 2.197

5.  Partial HIF-1alpha deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia.

Authors:  L A Shimoda; D J Manalo; J S Sham; G L Semenza; J T Sylvester
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-07       Impact factor: 5.464

6.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

Review 7.  Vascular endothelin in hypertension.

Authors:  Ernesto L Schiffrin
Journal:  Vascul Pharmacol       Date:  2005-06       Impact factor: 5.773

8.  Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn.

Authors:  P Kumar; N J Kazzi; S Shankaran
Journal:  Am J Perinatol       Date:  1996-08       Impact factor: 1.862

9.  HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin.

Authors:  Masanobu Morita; Osamu Ohneda; Toshiharu Yamashita; Satoru Takahashi; Norio Suzuki; Osamu Nakajima; Shimako Kawauchi; Masatsugu Ema; Shigeki Shibahara; Tetsuo Udono; Koji Tomita; Makoto Tamai; Kazuhiro Sogawa; Masayuki Yamamoto; Yoshiaki Fujii-Kuriyama
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

10.  Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex.

Authors:  Mindy A Maynard; Heng Qi; Jacky Chung; Eric H L Lee; Yukihiro Kondo; Shuntaro Hara; Ronald C Conaway; Joan W Conaway; Michael Ohh
Journal:  J Biol Chem       Date:  2003-01-21       Impact factor: 5.157

View more
  48 in total

1.  Genome-scale study of transcription factor expression in the branching mouse lung.

Authors:  John C Herriges; Lan Yi; Elizabeth A Hines; Julie F Harvey; Guoliang Xu; Paul A Gray; Qiufu Ma; Xin Sun
Journal:  Dev Dyn       Date:  2012-07-20       Impact factor: 3.780

Review 2.  Complex role of the HIF system in cardiovascular biology.

Authors:  Gabor Czibik
Journal:  J Mol Med (Berl)       Date:  2010-06-24       Impact factor: 4.599

Review 3.  Generating specificity and diversity in the transcriptional response to hypoxia.

Authors:  Urban Lendahl; Kian Leong Lee; Henry Yang; Lorenz Poellinger
Journal:  Nat Rev Genet       Date:  2009-11-03       Impact factor: 53.242

Review 4.  Hypoxia-inducible factor signaling in pulmonary hypertension.

Authors:  Soni Savai Pullamsetti; Argen Mamazhakypov; Norbert Weissmann; Werner Seeger; Rajkumar Savai
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

Review 5.  The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy.

Authors:  Najah Albadari; Shanshan Deng; Wei Li
Journal:  Expert Opin Drug Discov       Date:  2019-05-09       Impact factor: 6.098

Review 6.  Nuclear-cytoplasmatic shuttling of proteins in control of cellular oxygen sensing.

Authors:  Reinhard Depping; Wolfgang Jelkmann; Friederike Katharina Kosyna
Journal:  J Mol Med (Berl)       Date:  2015-03-27       Impact factor: 4.599

7.  Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA.

Authors:  Dongjian Hu; Annet Linders; Abir Yamak; Cláudia Correia; Jan David Kijlstra; Arman Garakani; Ling Xiao; David J Milan; Peter van der Meer; Margarida Serra; Paula M Alves; Ibrahim J Domian
Journal:  Circ Res       Date:  2018-10-12       Impact factor: 17.367

Review 8.  Regulation of angiogenesis by oxygen sensing mechanisms.

Authors:  Guo-Hua Fong
Journal:  J Mol Med (Berl)       Date:  2009-03-14       Impact factor: 4.599

9.  The active form of human aryl hydrocarbon receptor (AHR) repressor lacks exon 8, and its Pro 185 and Ala 185 variants repress both AHR and hypoxia-inducible factor.

Authors:  Sibel I Karchner; Matthew J Jenny; Ann M Tarrant; Brad R Evans; Hyo Jin Kang; Insoo Bae; David H Sherr; Mark E Hahn
Journal:  Mol Cell Biol       Date:  2009-04-20       Impact factor: 4.272

Review 10.  Now a Nobel gas: oxygen.

Authors:  Joachim Fandrey; Johannes Schödel; Kai-Uwe Eckardt; Dörthe M Katschinski; Roland H Wenger
Journal:  Pflugers Arch       Date:  2019-11-22       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.